メニュー

  1. 国立循環器病研究センター 病院 TOP
  2. 診療科・部門のご案内
  3. 脳血管部門 - 脳血管内科・脳神経内科
  4. さらに詳しく - 脳血管内科（脳内Aグループ）　2011年　論文業績

脳血管内科・脳神経内科

さらに詳しく
脳血管内科（脳内Aグループ）　2011年　論文業績

脳血管内科（脳内Aグループ）　2011年　論文業績

【原著】

  1. Hirata K, Kuge Y, Yokota C, Harada A, Kokame K, Inoue H, Kawashima H, Hanzawa H, Shono Y, Saji H, Minematsu K, Tamaki N: Gene and protein analysis of brain derived neurotrophic factor expression in relation to neurological recovery induced by an enriched environment in a rat stroke model. Neurosci Lett. 495: 210-215, 2011
  2. Kawano H, Yamamoto H, Miyata S, Izumi M, Hirano T, Toratani N, Kakutani I, Sheppard JA, Warkentin TE, Kada A, Sato S, Okamoto S, Nagatsuka K, Naritomi H, Toyoda K, Uchino M, Minematsu K: Prospective multicentre cohort study of heparin-induced thrombocytopenia in acute ischaemic stroke patients. Br J Haematol, 154: 378-386, 2011.
  3. Koga M, Kimura K, Shibazaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Nezu T, Maeda K, Minematsu K, Toyoda K: CHADS2 score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation： SAMURAI rt-PA registry. J Neurol Sci. 306: 49-53, 2011.
  4. Koga M, Toyoda K, Nakashima T, Hyun B, Uehara T, Yokota C, Nagatsuka K, Naritomi H, Minematsu K: Carotid duplex ultrasonography can predict outcome of intravenous alteplase therapy for hyperacute stroke. J Stroke Cerebrovasc Dis, 20: 24-29, 2011.
  5. Koga M, Uehara T, Yasui N, Hasegawa Y, Nagatsuka K, Okada Y, Minematsu K: Factors influencing cooperation among healthcare providers in a community-based stroke care system in Japan. J Stroke Cerebrovasc Dis, 20: 413-423, 2011.
  6. Kuwashiro T, Yasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H, Minematsu K: Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Cerebrovasc Dis, 31: 170-176, 2011.
  7. Mori E, Minematsu K, Nakagawara J, Yamaguchi T, for the Japan Alteplase Clinical Trial (J-ACT) Group： Factors predicting outcome in acute ischemic stroke patients treated with 0.6 mg/kg alteplase： Evidence from the Japan Alteplase Clinical Trial (J-ACT). J Stroke Cerebrovasc Dis, 20:517-522, 2011.
  8. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcom after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis, 31: 123-129, 2011.
  9. Naganuma M, Mori M, Nezu T, Makihara N, Koga M, Okada Y, Minematsu K, Toyoda K on behalf of the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators: Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry. Eur Neurol, 66: 37-41, 2011.
  10. Tomii Y, Matsuoka H, Torii T, Uehara T, Toyoda K, Minematsu K： A new ultrasound method for evaluating dysphasia in acute stroke patients. Int J Stroke, 6:279-280, 2011
  11. Tomii Y, Toyoda K, Suzuki R, Naganuma M, Fujinami J, Yokota C, Minematsu K: Effects of 24-hour blood pressure and heart rate recorded with ambulatory blood pressure monitoring on recovery from acute ischemic stroke. Stroke, 42: 3511-3517, 2011.
  12. Tomii Y, Toyoda K, Nakashima T, Nezu T, Koga M, Yokota C, Nagatsuka K, Minematsu K: Effects of hyperacute blood pressure and heart rate on stroke outcomes after intravenous tissue plasminogen activator. J Hypertens, 29: 1980-1987, 2011.
  13. Nagasawa　H, Yokota C, Toyoda K, Ito A, Minematsu K: High level of plasma adiponectin in acute stroke patients is associated with stroke mortality. J Neuro Sci, 304: 102-106, 2011.
  14. Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K: Early ischemic change on CT versus Deffusion-Weighted Imaging for patients with stroke receiving intravenous Recombinant Tissue-Type Plasminogen Activator therapy: Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry. Stroke, 42: 2196-2200, 2011.
  15. Shono Y, Yokota C, Kuge Y, Kido S, Harada A, Kokame K, Inoue H, Hotta M, Hirata K, Saji H, Tamaki N, Minematsu K: Gene expression associated with an enriched environment after transient focal ischemia. Brain Res, 1376: 60-65, 2011.
  16. Yakushiji Y, Yokota C, Yamada N, Kuroda Y, Minematsu K: Clinical characteristics by topographical distribution of brain microbleeds, with a particular emphasis on diffuse microbleeds. J Stroke Cerebrovasc Dis, 20: 214-221, 2011.
  17. Tanahashi N, Nakagawara J, Okada Y, Minematsu K, on behalf of the Challenge-Stroke Study Group: Candesartan cilexetil in the management of blood pressure for acute and recurrent stroke in Japan: the Challenge-Stroke study. Expert Rev Cardiovasc Ther, 9: 1115-1126, 2011.
  18. Fujimoto S, Toyoda K, Jinnouchi J, Yasaka M, Kitazono T, Okada Y: Differences in Diffusion-Weighted Image and Transesophageal Echocardiographical Findings in Cardiogenic, Paradoxical and Aortogenic Brain Embolism. Cerebrovasc Dis, 32:148-154, 2011.

【症例報告】

  1. Mori M, Yamamoto H, Koga M, Okatsu H, Shono Y, Toyoda K, Fukuda K, Iihara K, Yamada N, Minematsu K: Hyoid bone compression-induced repetitive occlusion and recanalization of the internal carotid artery in a patient with ipsilateral brain and retinal ischemia. Arch Neurol, 68: 258-259, 2011.

最終更新日：2021年10月08日

設定メニュー